COPD exacerbations: defining their cause and prevention

被引:813
|
作者
Wedzicha, Jadwiga A.
Seemungal, Terence A. R.
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Acad Unit Resp Med, London NW3 2PF, England
[2] UCL, London, England
[3] Univ W Indies, Dept Clin Med Sci, St Augustine, Trinidad Tobago
来源
LANCET | 2007年 / 370卷 / 9589期
关键词
D O I
10.1016/S0140-6736(07)61382-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 50 条
  • [21] Bronchodilator therapy in the prevention of COPD exacerbations
    Sobradillo Ecenarro, P.
    Garcia-Rivero, J. L.
    Lopez Caro, J. C.
    MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (07): : 479 - 488
  • [22] COPD Exacerbations Causes, Prevention, and Treatment
    Mackay, Alex J.
    Hurst, John R.
    MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (04) : 789 - +
  • [23] Optimizing bronchodilation in the prevention of COPD exacerbations
    Miravitlles, Marc
    Anzueto, Antonio
    Jardim, Jose R.
    RESPIRATORY RESEARCH, 2017, 18
  • [24] Metoprolol for the Prevention of Exacerbations of COPD Reply
    Dransfield, Mark T.
    Helgeson, Erika S.
    Connett, John E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1375 - 1376
  • [25] Antibiotic Prevention of Acute Exacerbations of COPD
    Wenzel, Richard P.
    Fowler, Alpha A., III
    Edmond, Michael B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04): : 340 - 347
  • [26] Prevention of Exacerbations in COPD Tiotropium versus Salmeterol
    Braun, J.
    PNEUMOLOGE, 2011, 8 (06): : 434 - 435
  • [27] Prediction and prevention of exacerbations and mortality in patients with COPD
    Kostikas, Konstantinos
    Clemens, Andreas
    Patalano, Francesco
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (07) : 739 - 753
  • [28] Antibiotic Prevention of Acute Exacerbations of COPD REPLY
    Wenzel, Richard P.
    Fowler, Alpha A., III
    Edmond, Michael B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1867 - 1867
  • [29] The role of bronchodilator treatment in the prevention of exacerbations of COPD
    Wedzicha, Jadwiga A.
    Decramer, Marc
    Seemungal, Terence A. R.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (06) : 1545 - 1554
  • [30] Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
    Vogelmeier, Claus
    Hederer, Bettina
    Glaab, Thomas
    Schmidt, Hendrik
    Rutten-van Molken, Maureen P. M. H.
    Beeh, Kai M.
    Rabe, Klaus F.
    Fabbri, Leonardo M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1093 - 1103